President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

Medicare announced an additional batch of 15 drugs subject to negotiation for discounts beginning in 2027. The law also called for penalties on drug companies that raised prices on ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...